Intelligence · Clinical Development
Pipeline search results
Programs matching “atra” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 17 pipeline programs matching "atra" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Azacitidine Combined With Venetoclax and ATRA group
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Satralizumab
Hoffmann-La Roche
NMDAR Autoimmune Encephalitis
1 trial -
Satralizumab
Hoffmann-La Roche
Neuromyelitis Optica (NMO)
1 trial -
Satralizumab, Satralizumab
Hoffmann-La Roche
Neuromyelitis Optica Spectrum Disorder (NMOSD)
1 trial -
dabigatran
Yung NA
Atrial Fibrillation
1 trial -
dabigatran dose 1
Boehringer Ingelheim
Atrial Fibrillation
1 trial -
dabigatran etexilate
Boehringer Ingelheim
Venous Thromboembolism
1 trial -
VESANOID 10 mg, capsule molle
The George Institute
Oligometastatic solid cancer
1 trial -
ATRA
United Therapeutics Europe Ltd
Pancreatic Adenocarcinoma
1 trial -
Dabigatran
BRIGHT MINDS BIOSCIENCES INC.
Mild Cognitive Impairment
1 trial -
Dabigatran Etexilate
CORCEPT THERAPEUTICS INC
Cushing Syndrome
1 trial -
Satraplatin in combo with vinorelbine
BRIGHT MINDS BIOSCIENCES INC.
Advanced Solid Tumors
1 trial -
ATRA+Arsenic
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Promyelocytic Leukemia
1 trial -
Dabigatran Etexilate
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Satralizumab 120 mg
Hoffmann-La Roche
Neuromyelitis Optica Spectrum Disorder
1 trial -
ATRA+Venetoclax+Azacitidine
The First People's Hospital of Lianyungang
AML, Adult
1 trial -
cisatracurium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ARDS
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.